BamSEC and AlphaSense Join Forces
Learn More

Agios Pharmaceuticals Inc. – Material Contracts

NASDAQ: AGIO    
Share price (7/8/26): $42.76    
Market cap (7/8/26): $2.543 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q 8 pages Agios Pharmaceuticals, Inc. Insider Trading Policy Adopted by the Board of Directors on April 16, 2026 Effective April 16, 2026
12/34/56
EX-10.37
from 10-K 11 pages Employment Agreement
12/34/56
EX-10.2
from 10-Q 12 pages Sublease Agreement
12/34/56
EX-10.4
from 10-K 5 pages Agios Pharmaceuticals, Inc. Amended and Restated 2013 Employee Stock Purchase Plan Amended and Restated on December 2, 2024
12/34/56
EX-10.1
from 10-Q 48 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions. Purchase and Sale Agreement Dated as of May 24, 2024 by and Between Agios Pharmaceuticals, Inc., as Seller and Royalty Pharma Investments 2019 Icav, as Purchaser
12/34/56
EX-10.21
from 10-K 25 pages Sublease Agreement
12/34/56
EX-10.4
from 10-Q 5 pages Agios Pharmaceuticals, Inc. Restricted Stock Unit Agreement
12/34/56
EX-10.3
from 10-Q 5 pages Agios Pharmaceuticals, Inc. Restricted Stock Unit Agreement
12/34/56
EX-10.2
from 10-Q 4 pages Agios Pharmaceuticals, Inc. Stock Option Agreement
12/34/56
EX-10.1
from 10-Q 11 pages December 16, 2022 Richa Poddar 32 Anderson Street #1 Boston, Ma 02114 Re: Confidential Separation Agreement and General Release Dear Richa
12/34/56
EX-10.43
from 10-K 5 pages Consulting Agreement
12/34/56
EX-10.38
from 10-K 12 pages Employment Agreement
12/34/56
EX-10.5
from 10-Q 16 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 18 pages Agios Pharmaceuticals, Inc. Amended and Restated Severance Benefits Plan Effective October 6, 2022
12/34/56
EX-10.5
from 10-Q 13 pages General Terms and Conditions
12/34/56
EX-10.4
from 10-Q 13 pages General Terms and Conditions
12/34/56
EX-10.3
from 10-Q 10 pages Agios Pharmaceuticals, Inc. Inducement Nonstatutory Stock Option Award Agreement
12/34/56
EX-10.2
from 10-Q 15 pages Employment Agreement
12/34/56
EX-10.1
from 10-Q 5 pages Consulting Agreement
12/34/56
EX-10.44
from 10-K 12 pages Sublease Agreement
12/34/56